This phase II combination trial of trastuzumab, docetaxel, and vinorelbine was initiated in July 2001 and was performed in the Minnie Pearl Cancer Research Network, a multicenter, community-based ...

vinorelbine, gemcitabine, irinotecan, or pemetrexed) in 502 patients with recurrent or metastatic cervical cancer who received no more than 2 prior systemic regimens in the recurrent or metastatic ...

The Food and Drug Administration approved Tivdak for metastatic cervical cancer that progressed on or after chemotherapy.

Overview A cancer that develops in the breast cells and progresses in stages. Few early symptoms may include new lump in the ...

The innovaTV 301 trial (NCT04697628) is a global, 1:1 randomized, open-label phase 3 trial evaluating Tivdak (tisotumab vedotin-tftv) versus investigator’s choice of single agent chemotherapy ...

During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, ...

(NYSE: PFE) announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for TIVDAK ® (tisotumab vedotin-tftv) for the treatment of ...

Discover all the brand names or Trade names of generic drug called Vinorelbine Tartrate. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking ...

The chemotherapy options included eribulin, vinorelbine, gemcitabine, and capecitabine. The coprimary endpoints were progression free survival (PFS), as assessed by blinded independent central ...

AstraZeneca and Daiichi Sankyo's Enhertu, a HER2-directed antibody drug conjugate (ADC), has demonstrated significant ...

Background: The combinations of trastuzumab/docetaxel and trastuzumab/vinorelbine are highly active in the treatment of patients with HER2-positive metastatic breast ...